Company Description
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues.
The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Country | United Kingdom |
Founded | 2022 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 25,408 |
CEO | Brian McNamara |
Contact Details
Address: The Heights, Building 5, First Floor Weybridge, KT13 0NY United Kingdom | |
Phone | 44 1932 822000 |
Website | haleon.com |
Stock Details
Ticker Symbol | HLN |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | GBP |
CIK Code | 0001900304 |
CUSIP Number | 405552100 |
ISIN Number | US4055521003 |
SIC Code | 2844 |
Key Executives
Name | Position |
---|---|
Brian James McNamara | Chief Executive Officer and Executive Director |
Tobias Hannes Hestler | Executive Officer |
Dawn Amanda Allen | Chief Financial Officer and Director |
Claire Dickson | Chief Digital and Technology Officer |
Sonya Ghobrial | Head of Investor Relations |
Adrian Charles Morris | General Counsel |
Tamara Rogers | Chief Marketing Officer |
Line De Decker | Chief Human Resources Officer |
Filippo Lanzi | President of EMEA and LatAm |
Keith Choy | President of Asia Pacific |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 15, 2024 | 6-K | Report of foreign issuer |
Nov 14, 2024 | 6-K | Report of foreign issuer |
Nov 13, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Nov 12, 2024 | 6-K | Report of foreign issuer |
Nov 8, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Nov 8, 2024 | 6-K | Report of foreign issuer |
Nov 8, 2024 | 6-K | Report of foreign issuer |
Nov 6, 2024 | 6-K | Report of foreign issuer |
Nov 6, 2024 | 6-K | Report of foreign issuer |
Nov 5, 2024 | 6-K | Report of foreign issuer |